GLS Pharmaceuticals – Oncology and Injectables
GLS
GLS Pharma Limited is an Indian pharmaceutical company based in Hyderabad that specialises in oncology. It was founded in 2004 and began manufacturing in 2015.
In 2022 Aurobindo Pharma, an Indian drugmaker also based in Hyderabad and listed on the NSE and BSE, bought a 51% controlling stake in GLS Pharma. In 2024 Aurobindo agreed to buy the remaining 49%, making GLS a wholly owned subsidiary. The deal was aimed at expanding Aurobindo's presence in the Indian oncology market.
GLS's portfolio consists of oral cancer drugs and injectable chemotherapy, as well as supportive care products. Its plant is in Hyderabad.
Unifarm carries GLS oncology medicines: Lomcap (lomustine) and Arsenam 10 (arsenic trioxide).